News

Launch of rare-cancer trial spurs many more

Publish date: April 4, 2014

 

EXPERT ANALYSIS FROM SARCOMA AND GIST 2014

Dr. Hensley said that her spouse is a Sanofi employee. Ms. Keat had no disclosures.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

FDA panel unanimously backs cobas HPV test as primary screening tool
MDedge Hematology and Oncology
Whole-genome sequencing not ready for prime time
MDedge Hematology and Oncology
The push for smaller, smarter cancer trials
MDedge Hematology and Oncology
Oophorectomy did not eliminate uterine cancer risk in BRCA1 mutation carriers
MDedge Hematology and Oncology
Bariatric surgery reduces uterine cancer risk
MDedge Hematology and Oncology
Ability to perform daily activities did not predict chemotherapy tolerability in elderly women
MDedge Hematology and Oncology
Sentinel lymph node mapping showed high diagnostic accuracy in endometrial cancer
MDedge Hematology and Oncology
Ascites predicts bevacizumab benefit in advanced ovarian cancer
MDedge Hematology and Oncology
Biomarkers identified that predict residual disease in ovarian cancer
MDedge Hematology and Oncology
Vaginal cuff brachytherapy plus chemotherapy no better than pelvic radiation in early endometrial cancer
MDedge Hematology and Oncology